Chapman Rowan E

Chapman Rowan E serves as a Director at Natera, Inc., a company focused on genetic testing and diagnostics in the healthcare sector. His recent insider trading activity, tracked through SEC Form 4 filings, highlights a series of sales from December 9, 2025, to June 30, 2026. Notably, he executed three sales, with the largest transaction valued at approximately $972.3K, reflecting a strategic approach to managing his holdings in Natera, Inc. (NTRA).